Stem Cell Therapy Innovation: Opening an Ageless Era

Dekabi Clinic is paving the way for an ageless era, transcending traditional disease treatment to overcome the limitations of aging and maintain youth and vitality. By integrating Eastern and Western medicine with energy medicine, Dekabi’s cutting-edge approach offers sustainable health management and a new opportunity for life.

A New Paradigm in Diabetes Treatment: Stem Cell Innovation Unique Technologies to Restore Youth

Dekabi’s stem cell therapy promotes natural and healthy anti-aging effects through skin regeneration and cell activation. Particularly for diabetes patients, it reactivates pancreatic β-cell functions, fundamentally improving blood sugar control. According to a 2020 study published in Cell Stem Cell, stem cell therapy enhances blood glucose stability by over 35% through pancreatic tissue regeneration, significantly improving insulin sensitivity.

Currently, approximately 415 million people worldwide suffer from diabetes, a number expected to rise to 642 million by 2040, representing about 10% of the global population (Source: Diabetes.co.uk).

Integration of Eastern and Western Medicine with Energy Medicine

Dekabi combines traditional Eastern medicine with the latest Western medical technologies, applying the principles of energy medicine to go beyond symptom relief and achieve fundamental bodily regeneration and recovery.

Effective Treatment Outcomes:

• Hemoglobin A1c (HbA1c): 7.3% → 5.45% (Significant short-term reduction)

• Triglycerides: 616 mg/dL → 187 mg/dL (Effective improvement)

These scientifically proven results demonstrate the distinctive competitive edge of Dekabi’s therapies.

Clinical Evidence and Sustainable Treatment

With 21 years of accumulated clinical experience and scientific data, Dekabi offers personalized stem cell therapies. The intensive 7-day treatment program effectively addresses age-related changes and diabetes-related complications.

Prominent Case Studies:

• Shanghai: A 59-year-old male successfully cured of type 2 diabetes through stem cell therapy. Blood sugar was controlled within 11 weeks without insulin injections.

• Tianji: A 25-year-old female overcame type 1 diabetes with her own cell-derived stem cell transplant, resuming insulin production within three months and maintaining normal blood sugar levels.

These cases highlight the transformative potential of stem cell therapy in diabetes management and treatment, signaling exciting prospects for future research and clinical applications.